Rymedi raises $9m to help global healthcare infrastructure

14
Photo: OsloMetX/Pixabay

Rymedi, a healthcare data exchange platform with advanced blockchain security, has announced a Series A totaling $9 million with plans to expand the reach of their platform.

 The round was co-led by RW3 Ventures and White Star Capital with participation from Blockchange Ventures, Avalanche’s Blizzard Fund, and strategic angel investors from the healthcare industry.

Rymedi, which serves more than 1 million patients in more than 1,200 locations across the US, Africa, and Australia, will use the financing to increase data security and healthcare record accessibility for patients while reducing data entry errors and costs for healthcare data infrastructures on a global scale.

 The Rymedi platform, which currently supports Clemson University and many other large organizations throughout the world, removes the friction of a manual, paper filled operation to quickly connect with customers and patients and scale lab processes with higher testing throughput and lower total cost of ownership.

 “Our decentralized data platform is diminishing roadblocks that healthcare systems have faced for far too long,” said David Stefanich, CEO and founder of Rymedi.

“Data entry errors and healthcare compliance issues slow the development of life-saving research, patient care, and occupational health processes. We are improving the overall healthcare experience with this technology and are proud to make a larger global impact as we scale our services with this round of funding.”

 In the areas of occupational health, clinical trials, and laboratory information management systems, it automates data transfer with flexible interoperability, streamlines data entry with real-time results, and meets global regulatory compliance standards with what the company said is unrivaled security. This is all made possible by Rymedi’s blockchain-based backend, which is suited to facilitate data access across multiple parties and platforms.